Skip to main content

Cleveland Clinic won't carry controversial Alzheimer's drug

The Cleveland Clinic said it will not carry Biogen’s controversial Alzheimer’s drug after a panel of experts “reviewed all available scientific evidence on this medication.”
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.